S. Gu

发表

Landscape of B cell immunity and related immune evasion in human cancers

Jun S. Liu, N. Hacohen, Jun Liu, 2018, Nature Genetics.

MYC drives aggressive prostate cancer by disrupting transcriptional pause release at androgen receptor targets

Avery S. Feit, Henry W. Long, M. Loda, 2021, Nature Communications.

In Vivo CRISPR Screens Identify E3 Ligase Cop1 as a Modulator of Macrophage Infiltration and Cancer Immunotherapy Target

Clifford A. Meyer, Henry W. Long, Y. Zhang, 2020, bioRxiv.

IKAROS and MENIN Coordinate Therapeutically Actionable Leukaemogenic Gene Expression in MLL-r Acute Myeloid Leukaemia

S. Armstrong, A. Letai, X. Liu, 2022, Nature Cancer.

MetaTiME: Meta-components of the Tumor Immune Microenvironment

Clifford A. Meyer, Myles A Brown, X. Liu, 2022, bioRxiv.

Machine learning on syngeneic mouse tumor profiles to model clinical immunotherapy response

Myles A Brown, X. Liu, Zexian Zeng, 2022, Science advances.

A Community Challenge to Predict Clinical Outcomes After Immune Checkpoint Blockade in Non-Small Cell Lung Cancer

J. Szustakowski, T. Laajala, Raghvendra Mall, 2022, bioRxiv.

MetaTiME: Meta-components of the Tumor Immune Microenvironment

Clifford A. Meyer, Myles A Brown, X. Liu, 2023, bioRxiv.

Data-driven discovery of targets for bipotent anticancer drugs identifies Estrogen Related Receptor Alpha

Clifford A. Meyer, Phillip B. Nicol, Jun Liu, 2021, bioRxiv.

Immune receptor repertoires in pediatric and adult acute myeloid leukemia

N. Hacohen, X. Liu, A. Sahu, 2019, Genome Medicine.

Clonal tracing reveals diverse patterns of response to immune checkpoint blockade

Clifford A. Meyer, Henry W. Long, Y. Zhang, 2020, Genome biology.

CRISPR Screens Identify Essential Cell Growth Mediators in BRAF Inhibitor-resistant Melanoma

Shirley X. Liu, G. Boland, A. Sahu, 2020, Genom. Proteom. Bioinform..

CRISPR Screens Identify Essential Cell Growth Mediators in BRAF-inhibitor Resistant Melanoma

Myles Brown, Nicole Traugh, Sailing Shi, 2019, bioRxiv.

Checkpoint blockade-induced CD8+ T cell differentiation in head and neck cancer responders

Katie M. Campbell, O. Griffith, X. Liu, 2022, Journal for ImmunoTherapy of Cancer.

MYC drives aggressive prostate cancer by disrupting transcriptional pause release at androgen receptor targets

Henry W. Long, M. Loda, M. Freedman, 2021, Nature Communications.

CoBRA: Containerized Bioinformatics workflow for Reproducible ChIP/ATAC-seq Analysis - from differential peak calling to pathway analysis

Len Taing, Xintao Qiu, Avery S. Feit, 2020, bioRxiv.

Landscape of B cell immunity and related immune evasion in human cancers

N. Hacohen, Jun Liu, X. Liu, 2018, Nature Genetics.

Therapeutically increasing MHC-I expression potentiates immune checkpoint blockade.

Clifford A. Meyer, Henry W. Long, X. Liu, 2021, Cancer discovery.

Clonal tracing reveals diverse patterns of response to immune checkpoint blockade

Clifford A. Meyer, Henry W. Long, X. Liu, 2020, Genome Biology.

TISMO: syngeneic mouse tumor database to model tumor immunity and immunotherapy response

X. Liu, G. Freeman, K. Yates, 2021, Nucleic Acids Res..

A Molecular Switch between Mammalian MLL Complexes Dictates Response to Menin–MLL Inhibition

Francisco J. Sánchez-Rivera, S. Armstrong, S. Lowe, 2022, bioRxiv.

Hippo signaling pathway regulates cancer cell-intrinsic MHC-II expression.

X. Liu, F. Hodi, S. Rodig, 2022, Cancer immunology research.

Pan-ERBB kinase inhibition augments CDK4/6 inhibitor efficacy in oesophageal squamous cell carcinoma

Henry W. Long, M. Meyerson, A. Bass, 2021, Gut.

700 Increasing MHC-I expression to potentiate immune checkpoint blockade therapy

Clifford A. Meyer, Henry W. Long, G. Freeman, 2021, Journal for ImmunoTherapy of Cancer.

Discovery of Targets for Immune–Metabolic Antitumor Drugs Identifies Estrogen-Related Receptor Alpha

Clifford A. Meyer, Phillip B. Nicol, Jun Liu, 2022, Cancer discovery.

MetaTiME integrates single-cell gene expression to characterize the meta-components of the tumor immune microenvironment

Clifford A. Meyer, X. Liu, Chenfei Wang, 2023, Nature communications.

High IL2RA mRNA expression is an independent adverse prognostic biomarker in core binding factor and intermediate-risk acute myeloid leukemia

Yunhua Deng, Wei Zhou, Wei Liu, 2019, Journal of Translational Medicine.

High IL2RA mRNA expression is an independent adverse prognostic biomarker in core binding factor and intermediate-risk acute myeloid leukemia

Shengqing Gu, Yunhua Deng, D. Hu, 2019, Journal of Translational Medicine.

Machine Learning Modeling of Protein-intrinsic Features Predicts Tractability of Targeted Protein Degradation

Shourya S. Roy Burman, X. Liu, C. Tokheim, 2021, bioRxiv.

In vivo CRISPR screens identify the E3 ligase Cop1 as a modulator of macrophage infiltration and cancer immunotherapy target

Clifford A. Meyer, Henry W. Long, Y. Zhang, 2021, Cell.

CoBRA: Containerized Bioinformatics Workflow for Reproducible ChIP/ATAC-seq Analysis

Henry W. Long, Len Taing, P. Cejas, 2021, Genom. Proteom. Bioinform..

Discovery of Targets for Immune–Metabolic Antitumor Drugs Identifies Estrogen-Related Receptor Alpha

Clifford A. Meyer, Phillip B. Nicol, Jun Liu, 2023, Cancer discovery.